Trials / Unknown
UnknownNCT05229029
RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy
A Multicenter, Randomized, Double-blind Clinical Trial of TCM in Reducing CRF Caused by Chemotherapy in Cancer Patients
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 196 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of Chinese herbal compound in improving fatigue symptoms and quality of life in patients with chemotherapy.
Detailed description
In this study, symptomatic indicators and quality of life were used as the main evaluation indicators. Patients with moderate to severe CRF who received dual drug chemotherapy were given traditional Chinese medicine compound and placebo intervention respectively. The data of fatigue symptoms, quality of life, sleep quality, blood routine test, liver and kidney function were observed and compared, so as to verify the traditional Chinese medicine compound prescription in improving the CRF symptoms and quality of life of chemotherapy patients validity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TCM Formula | TCM herbs：White peony 10g, angelica 10g, Astragalus 20g, Atractylodes macrocephala 10g, tangerine peel 6g, Poria cocos 10g, raw land 10g, cinnamon 3g, Polygala tenuifolia 6g, Schisandra chinensis 6g, raw licorice 6g. |
| DRUG | Placebo | Mainly made of dextrin and caramel, containing 1/30 concentration of experimental group drugs |
Timeline
- Start date
- 2020-04-02
- Primary completion
- 2023-09-01
- Completion
- 2024-06-30
- First posted
- 2022-02-08
- Last updated
- 2024-01-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05229029. Inclusion in this directory is not an endorsement.